Isoeffect Calculations in Adaptive Radiation Therapy and Treatment Individualization

Adaptive Radiation Therapy

Volumn , Issue , 2011, Pages 105-123

  Stewart, Robert D ^a   Park, Joo Han ^a   Carlson, David J ^b  

^a PURDUE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893423849     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b10517-14     Document Type: Chapter

References (106)

1. Allan, J. M., and L. B. Travis. 2005. Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 5:943-55.
2. Astreinidou, E., A. Bel, C. P. Raaijmakers, C. H. Terhaard, and J. J. Lagendijk. 2005. Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys 61:938-44.
3. Azzam, E. I., S. M. De Toledo, and J. B. Little. 2001. Direct evi-dence for the participation of gap junction-mediated inter-cellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A 98:473-8.
4. Azzam, E. I., S. M. De Toledo, and J. B. Little. 2003. Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect. Oncogene 22:7050-7.
5. Bajzer, Z., 1999. Gompertzian growth as a self-similar and allo-metric process. Growth Dev Aging 63:3-11.
6. Barker, Jr., J. L., A. S. Garden, K. K. Ang, et al. 2004. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59:960-70.
7. Bedford, J. S. 1991. Sublethal damage, potentially lethal dam-age, and chromosomal aberrations in mammalian cells exposed to ionizing radiations. Int J Radiat Oncol Biol Phys 21:1457-69.
8. Bel, A., M. Van Herk, and J. V. Lebesque. 1996. Target margins for random geometrical treatment uncertainties in conformal radiotherapy. Med Phys 23:1537-45.
9. Bel, A., P. H. Vos, P. T. Rodrigus, et al. 1996. High-precision pros-tate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys 35:321-32.
10. Bentzen, S. M. 1992. Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma. Int J Radiat Biol 61:417-23.
11. Bentzen, S. M. 2006. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer 6:702-13.
12. Bentzen, S. M., H. D. Thames, and J. Overgaard. 1990. Does varia-tion in the in vitro cellular radiosensitivity explain the shal-low clinical dose-control curve for malignant melanoma? Int J Radiat Biol 57:117-26.
13. Brenner, D. J. 2008. The linear-quadratic model is an appropri-ate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18:234-9.
14. Brenner, D. J., and D. E. Herbert. 1997. The use of the linear-quadratic model in clinical radiation oncology can be defended on the basis of empirical evidence and theoretical argument. Med Phys 24:1245-8.
15. Brenner, D. J., L. R. Hlatky, P. J. Hahnfeldt, Y. Huang, and R. K. Sachs. 1998. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat Res 150:83-91.
16. Brizel, D. M., G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst. 1997. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38:285-9.
17. Brown, J. M. 1979. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52:650-6.
18. Brown, J. M. 1999. The hypoxic cell: A target for selective can-cer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59:5863-70.
19. Brown, J. M. 2000. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies. Mol Med Today 6:157-62.
20. Brown, J. M., and W. R. Wilson. 2004. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4:437-47.
21. Bryant, P. E. 2004. Repair and chromosomal damage. Radiother Oncol 72:251-6.
22. Calderon, C. P., and T. A. Kwembe. 1991. Modeling tumor growth. Math Biosci 103:97-114.
23. Carlson, D. J., R. D. Stewart, X. A. Li, et al. 2004. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys Med Biol 49:4477-91.
24. Carlson, D. J., R. D. Stewart, and V. A. Semenenko. 2006. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Med Phys 33:3105-15.
25. Carlson, D. J., R. D. Stewart, V. A. Semenenko, and G. A. Sandison. 2008. Combined use of Monte Carlo DNA damage simulations and deterministic repair models to examine putative mechanisms of cell killing. Radiat Res 169:447-59.
26. Chadwick, K. H., and H. P. Leenhouts. 1973. A molecular theory of cell survival. Phys Med Biol 18:78-87.
27. Chavaudra, N., J. Bourhis, and N. Foray. 2004. Quantified rela-tionship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: A study of 19 human tumour cell lines from different origin. Radiother Oncol 73:373-82.
28. Chen, M., W. Lu, Q. Chen, K. Ruchala, and G. Olivera. 2008. Adaptive fractionation therapy: II. Biological effective dose. Phys Med Biol 53:5513-25.
29. Cornforth, M. N., and J. S. Bedford. 1987. A quantitative compar-ison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts. Radiat Res 111:385-405.
30. Curtis, S. B. 1986. Lethal and potentially lethal lesions induced by radiation-a unified repair model. Radiat Res 106:252-70.
31. Dale, R. G. 1985. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58:515-28.
32. Dasu, A., and J. Denekamp. 1998. New insights into factors influ-encing the clinically relevant oxygen enhancement ratio. Radiother Oncol 46:269-77.
33. Dasu, A., I. Toma-Dasu, and J. F. Fowler. 2003. Should single or distributed parameters be used to explain the steep-ness of tumour control probability curves? Phys Med Biol 48:387-97.
34. Ebert, M. A. 2000. Viability of the EUD and TCP concepts as reli-able dose indicators. Phys Med Biol 45:441-57.
35. Emami, B., J. Lyman, A. Brown, et al. 1991. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109-22.
36. Fontenot, J. D., A. K. Lee, and W. D. Newhauser. 2009. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 74:616-22.
37. Frankenberg, D., H. J. Brede, U. J. Schrewe, et al. 1999. Induction of DNA double-strand breaks by 1H and 4He lons in primary human skin fibroblasts in the LET range of 8 to 124 keV/microm. Radiat Res 151:540-9.
38. Frankenberg-Schwager, M. 1990. Induction, repair and biological relevance of radiation-induced DNA lesions in eukaryotic cells. Radiat Environ Biophys 29:273-92.
39. Fyles, A. W., M. Milosevic, R. Wong, et al. 1998. Oxygenation pre-dicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48:149-56.
40. Guerrero, M., and X. A. Li. 2004. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 49:4825-35.
41. Hall, E. J. 2003. The bystander effect. Health Phys 85:31-5.
42. Hei, T. K., L. J. Wu, S. X. Liu, et al. 1997. Mutagenic effects of a single and an exact number of alpha particles in mamma-lian cells. Proc Natl Acad Sci U S A 94:3765-70.
43. Hlatky, L., R. K. Sachs, M. Vazquez, and M. N. Cornforth. 2002. Radiation-induced chromosome aberrations: Insights gained from biophysical modeling. Bioessays 24:714-23.
44. Hockel, M., K. Schlenger, B. Aral, et al. 1996. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509-15.
45. Howe, O., J. O’Sullivan, B. Nolan, et al. 2009. Do radiation-induced bystander effects correlate to the intrinsic radio-sensitivity of individuals and have clinical significance? Radiat Res 171:521-9.
46. Jackson, S. P. 2002. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-96.
47. Jeggo, P. A. 2002. The fidelity of repair of radiation damage. Radiat Prot Dosimetry 99:117-22.
48. Joiner, M. C. 1994. Induced radioresistance: An overview and historical perspective. Int J Radiat Biol 65:79-84.
49. Joiner, M. C., P. Lambin, and B. Marples. 1999. Adaptive response and induced resistance. C R Acad Sci III 322:167-75.
50. Kallman, R. F. 1972. The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology 105:135-42.
51. Koch, C. J., C. C. Stobbe, and E. A. Bump. 1984. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: Quantitative differences found using the radiation sensitizing agent misonidazole or oxygen. Radiat Res 98:141-53.
52. Kuhne, M., E. Riballo, N. Rief, et al. 2004. A double-strand break repair defect in ATM-deficient cells contributes to radio-sensitivity. Cancer Res 64:500-8.
53. Leong, J., 1987. Implementation of random positioning error in computerised radiation treatment planning systems as a result of fractionation. Phys Med Biol 32:327-34.
54. Levegrun, S., A. Jackson, M. J. Zelefsky, et al. 2001. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data. Int J Radiat Oncol Biol Phys 51:1064-80.
55. Lian, J., and L. Xing. 2004. Incorporating model parameter uncertainty into inverse treatment planning. Med Phys 31:2711-20.
56. Liang, F., M. Han, P. J. Romanienko, and M. Jasin. 1998. Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc Natl Acad Sci U S A 95:5172-7.
57. Lin, Z., J. Mechalakos, S. Nehmeh, et al. 2008. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 70:1219-28.
58. Ling, C. C., J. Humm, S. Larson, et al. 2000. Towards multidi-mensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47:551-60.
59. Ling, C. C., H. B. Michaels, E. R. Epp, and E. C. Peterson. 1980. Interaction of misonidazole and oxygen in the radiosensi-tization of mammalian cells. Int J Radiat Oncol Biol Phys 6:583-9.
60. Little, M. P. 2009. Cancer and non-cancer effects in Japanese atomic bomb survivors. J Radiol Prot 29:A43-59.
61. Lu, W., M. Chen, Q. Chen, K. Ruchala, and G. Olivera. 2008. Adaptive fractionation therapy: I. Basic concept and strat-egy. Phys Med Biol 53:5495-511.
62. Marples, B., B. G. Wouters, S. J. Collis, A. J. Chalmers, and M. C. Joiner. 2004. Low-dose hyper-radiosensitivity: A consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 161:247-55.
63. Mcaneney, H., and S. F. O’rourke. 2007. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy. Phys Med Biol 52:1039-54.
64. Moiseenko, V., 2004. Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low alpha/beta cancers. Acta Oncol 43:499-502.
65. Mothersill, C., and C. Seymour. 1997. Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. Int J Radiat Biol 71:421-7.
66. Mothersill, C., and C. Seymour. 2001. Radiation-induced bystander effects: Past history and future directions. Radiat Res 155:759-67.
67. Mothersill, C., and C. B. Seymour. 1998. Cell-cell contact dur-ing gamma irradiation is not required to induce a bystander effect in normal human keratinocytes: Evidence for release during irradiation of a signal controlling survival into the medium. Radiat Res 149:256-62.
68. Movsas, B., J. D. Chapman, A. L. Hanlon, et al. 2002. Hypoxic prostate/muscle pO2 ratio predicts for biochemical fail-ure in patients with prostate cancer: Preliminary findings. Urology 60:634-9.
69. Nagasawa, H., and J. B. Little. 1992. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res 52:6394-6.
70. Nahum, A. E., B. Movsas, E. M. Horwitz, C. C. Stobbe, and J. D. Chapman. 2003. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys 57:391-401.
71. Natarajan, A. T., and F. Palitti. 2008. DNA repair and chromo-somal alterations. Mutat Res 657:3-7.
72. Nelson, J. M., A. L. Brooks, N. F. Metting, et al. 1996. Clastogenic effects of defined numbers of 3.2 MeV alpha particles on individual CHO-K1 cells. Radiat Res 145:568-74.
73. Newhauser, W. D., J. D. Fontenot, A. Mahajan, et al. 2009. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 54:2277-91.
74. Niemierko, A., 1997. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 24:103-10.
75. Nordsmark, M., M. Overgaard, and J. Overgaard. 1996. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41:31-9.
76. O’daniel, J. C., A. S. Garden, D. L. Schwartz, et al. 2007. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: Is what you plan what you get? Int J Radiat Oncol Biol Phys 69:1290-6.
77. Park, C., L. Papiez, S. Zhang, M. Story, and R. D. Timmerman. 2008. Universal survival curve and single fraction equiva-lent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70:847-52.
78. Prise, K. M., O. V. Belyakov, M. Folkard, and B. D. Michael. 1998. Studies of bystander effects in human fibroblasts using a charged particle microbeam. Int J Radiat Biol 74:793-8.
79. Prise, K. M., S. Davies, and B. D. Michael. 1993. Evidence for induction of DNA double-strand breaks at paired radical sites. Radiat Res 134:102-6.
80. Rofstad, E. K., K. Sundfor, H. Lyng, and C. G. Trope. 2000. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 83:354-9.
81. Rothkamm, K., and M. Lobrich. 2003. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 100:5057-62.
82. Sachs, R. K., and D. J. Brenner. 1998. The mechanistic basis of the linear-quadratic formalism. Med Phys 25:2071-3.
83. Sachs, R. K., P. Hahnfeld, and D. J. Brenner. 1997. The link between low-LET dose-response relations and the under-lying kinetics of damage production/repair/misrepair. Int J Radiat Biol 72:351-74.
84. Savage, J. R. 1998. A brief survey of aberration origin theories. Mutat Res 404:139-47.
85. Semenenko, V. A., and R. D. Stewart. 2004. A fast Monte Carlo algorithm to simulate the spectrum of DNA damages formed by ionizing radiation. Radiat Res 161:451-7.
86. Semenenko, V. A., and R. D. Stewart. 2005. Monte Carlo simu -lation of base and nucleotide excision repair of clustered DNA damage sites: II. Comparisons of model predictions to measured data. Radiat Res 164:194-201.
87. Semenenko, V. A., R. D. Stewart, and E. J. Ackerman. 2005. Monte Carlo simulation of base and nucleotide excision repair of clustered DNA damage sites: I. Model properties and pre-dicted trends. Radiat Res 164:180-93.
88. Stewart, R. D., and X. A. Li. 2007. BGRT: Biologically guided radiation therapy-the future is fast approaching! Med Phys 34:3739-51.
89. Suit, H., S. Skates, A. Taghian, P. Okunieff, and J. T. Efird. 1992. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol 25:251-60.
90. Sundfor, K., H. Lyng, C. G. Trope, and E. K. Rofstad. 2000. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 54:101-7.
91. Sutherland, B. M., P. V. Bennett, H. Schenk, et al. 2001. Clustered DNA damages induced by high and low LET radiation, including heavy ions. Phys Med 17(Suppl 1):202-4.
92. Thames, H. D. 1985. An ‘incomplete-repair’ model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med 47:319-39.
93. Timmerman, R., L. Papiez, R. Mcgarry, et al. 2003. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124:1946-55.
94. Tobias, C. A. 1985. The repair-misrepair model in radiobiology: Comparison to other models. Radiat Res Suppl 8:S77-95.
95. Tome, W. A., and J. F. Fowler. 2003. On the inclusion of prolifera-tion in tumour control probability calculations for inhomo-geneously irradiated tumours. Phys Med Biol 48:N261-8.
96. Travis, E. L. 2001. Organizational response of normal tissues to irradiation. Semin Radiat Oncol 11:184-96.
97. Tucker, S. L., and J. M. Taylor. 1996. Improved models of tumour cure. Int J Radiat Biol 70:539-53.
98. Tucker, S. L., H. D. Thames, and J. M. Taylor. 1990. How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat Res 124:273-82.
99. Vaupel, P., and M. Hockel. 1995. Oxygenation status of human tumors: A reappraisal of using computerized pO2 histogra-phy. In Tumor Oxygenation, ed. P. Vaupel, D. Kelleher and M. Gunderoth. Stuttgart, Germany: Gustav Fischer Verlag. 219-32.
100. Verellen, D., M. De Ridder, K. Tournel, et al. 2008. An overview of volumetric imaging technologies and their quality assur-ance for IGRT. Acta Oncol 47:1271-8.
101. Wallace, S. S. 1998. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat Res 150:S60-79.
102. Wang, J. Z., X. A. Li, W. D. D’souza, and R. D. Stewart. 2003. Impact of prolonged fraction delivery times on tumor con-trol: A note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 57:543-52.
103. Warkentin, B., P. Stavrev, N. A. Stavreva, and B. G. Fallone. 2005. Limitations of a TCP model incorporating population het-erogeneity. Phys Med Biol 50:3571-88.
104. Webb, S., P. M. Evans, W. Swindell, and J. O. Deasy. 1994. A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume. Phys Med Biol 39:2091-8.
105. Webb, S., and A. E. Nahum. 1993. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 38:653-66.
106. Whillans, D. W., and J. W. Hunt. 1982. A rapid-mixing compari-son of the mechanisms of radiosensitization by oxygen and misonidazole in CHO cells. Radiat Res 90:126-41.